Variable | Overall | Cohort A | Cohort B | ||||||
Non-CP (n=9633) | CP (n=68) | P value | Non-CP (n=4637) | CP (n=24) | P value | Non-CP (n=4996) | CP (n=44) | P value | |
Mean age and SD | 65±12 | 70±11 | 0.001 | 65±13 | 69±11 | 0.133 | 65±12 | 70±13 | 0.006 |
Gender | |||||||||
Male, n (%) | 7029 (73) | 44 (65) | 0.127 | 3436 (74) | 13 (54) | 0.026 | 3590 (72) | 31 (70) | 0.837 |
Smoking status | |||||||||
Current, n (%) | 2229 (23) | 24 (35) | 0.018 | 1157 (25) | 5 (21) | 0.642 | 1072 (21) | 19 (43) | <0.001 |
Medical history | |||||||||
Hypertension, n (%) | 5719 (59) | 46 (68) | 0.166 | 2652 (57) | 17 (71) | 0.178 | 3067 (61) | 29 (66) | 0.540 |
Diabetes, n (%) | 2610 (27) | 15 (22) | 0.352 | 1017 (22) | 3 (13) | 0.265 | 1593 (32) | 12 (27) | 0.513 |
ACS, n (%) | 6599 (69) | 49 (72) | 0.529 | 3334 (72) | 20 (83) | 0.213 | 3265 (65) | 29 (66) | 0.938 |
Stable angina, n (%) | 3034 (31) | 19 (28) | 0.529 | 1327 (29) | 4 (17) | 0.196 | 1707 (34) | 15 (34) | 0.992 |
CKD, n (%) | 341 (4) | 5 (7) | 0.091 | 177 (4) | 1 (4) | 0.929 | 164 (3) | 4 (9) | 0.034 |
Previous MI, n (%) | 2833 (29) | 22 (32) | 0.596 | 1266 (27) | 7 (29) | 0.838 | 1567 (31) | 15 (34) | 0.698 |
Hypercholesterolaemia, n (%) | 4763 (49) | 36 (53) | 0.566 | 2421 (52) | 17 (71) | 0.068 | 2342 (47) | 19 (43) | 0.625 |
PVD, n (%) | 463 (5) | 8 (12) | 0.008 | 218 (5) | 1 (4) | 0.902 | 245 (5) | 7 (16) | <0.001 |
History of CABG, n (%) | 874 (9) | 8 (12) | 0.442 | 424 (9) | 3 (13) | 0.570 | 450 (9) | 5 (11) | 0.587 |
Family history of CAD, n (%) | 4014 (42) | 26 (38) | 0.567 | 1710 (37) | 9 (38) | 0.950 | 2304 (46) | 17 (39) | 0.322 |
ACS, acute coronary syndrome; CABG, coronary artery bypass graft; CAD, coronary artery disease; CKD, chronic kidney disease; CP, coronary perforation; MI, myocardial infarction; PVD, peripheral vascular disease.